Rodolphe Clerval, Coave Therapeutics CEO
Coave raises €32M Series A despite being two years away from the clinic
More than many other corporate VCs, Novo Holdings has the cash to take risks. Its most recent is co-leading the €32 million ($33 million) Series …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
